business

US Appeals Court Reinstates Lawsuits Connecting Tylenol to Autism Risk
13 Temmuz 2026Financial Times
- A federal appeals court in New York has revived lawsuits that link the painkiller Tylenol to autism, determining that a trial judge improperly excluded expert testimony when dismissing the cases. This ruling allows the lawsuits to proceed, potentially opening the door for further examination of the drug's safety.
- The decision has significant implications for both public health and pharmaceutical liability.
- The lawsuits allege that the use of Tylenol during pregnancy may be linked to an increased risk of autism in children, a claim that has gained traction among some researchers and advocates. The initial dismissal of these cases was based on the exclusion of expert opinions, which the appeals court has now overturned,…
- The revival of these lawsuits highlights the ongoing debate surrounding the safety of widely used medications like Tylenol. With expert testimony now permitted, the court's decision may prompt a deeper investigation into the potential risks associated with acetaminophen, especially concerning its effects on neurolog…
NewsAI özeti
This summary is for informational purposes only and does not constitute legal advice.
Orijinal Kaynak
Tam teknik rapor ve canlı veriler için yayıncının web sitesini ziyaret edin.
Kaynağı Görüntüleİlgili Haberler
Tümünü GörNewsAI Mobil Uygulamaları
Her yerde okuyun. iOS ve Android için ödüllü uygulamalarımızı indirin.

